About IMMvention Therapeutix
IMMvention Therapeutix is a private company based in Durham, North Carolina. It has reported $8,899,998 raised in two offerings on Form D since December 2020. Its chief executive is Anil Goyal.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 23, 2022 | Jan 10, 2023 | $1,999,999of $3.9M target | 4 | $499K | EquityRule 506(b) | Form D ↗ |
| Dec 7, 2020 | Dec 28, 2020amended Nov 19, 2021 | $6,899,999fully sold | 5 | $1.3M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $8,899,998 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on IMMvention Therapeutix's Form D filed Jan 10, 2023.
JT
Jenny Ting
Director
MT
Marilyn Thompson
Executive officer
MV
Mark Velleca
Director
AG
Anil Goyal
Chief Executive Officer and director
LO
Lev Osherovich
Director
BS
Benjamin Scruggs
Director
MC
Matthew Cohen
Director
Earlier filings also listed Mark Vellaca (director, last listed Nov 2021).